Magda Szubanski cancer remission update: stage 4 lymphoma

Magda Szubanski, the Australian icon behind Sharon Strzelecki in Kath & Kim, shared a stage 4 cancer diagnosis in May 2025 and turned her candid updates into a public case study in mantle cell lymphoma awareness. Here’s what her journey from diagnosis to remission reveals about this rare blood cancer and the treatment path she chose.

Age at diagnosis: 63 ·
Cancer type: Mantle cell lymphoma (stage 4) ·
Announced remission: February 2026 ·
Instagram followers: 406,000+ ·
Notable role: Sharon Strzelecki in Kath & Kim

Quick snapshot

1Confirmed facts

Diagnosed with stage 4 mantle cell lymphoma in May 2025 (Instagram (Magda Szubanski))
Announced remission in February 2026 (ABC News)
Known for role as Sharon Strzelecki in Kath & Kim (Instagram (Magda Szubanski))

2What’s unclear

Specific details of her ongoing treatment plan are not publicly detailed
Long-term prognosis for her specific case is not publicly available
Her description of the cancer as “rare and fast-moving” is based on her own social media account
Her statement about receiving the Nordic protocol treatment comes from a single personal update

3Timeline signal

Diagnosis announced May 2025 → Remission announced February 2026 — a 9-month treatment window (ABC News)

4What’s next

Ongoing monitoring for recurrence — remission is not a complete cure (ABC News)

Eight key facts about Magda Szubanski, one pattern: a public figure whose health crisis became a rare window into a little-known cancer.

Attribute	Detail
Full name	Magdalene Mary Therese Szubanski
Date of birth	12 April 1961
Place of birth	Liverpool, England, UK
Nationality	Australian
Occupation	Comedian, actress, author, LGBT rights advocate
Notable work	Kath & Kim, Babe, Fast Forward
Cancer diagnosis	Stage 4 mantle cell lymphoma (May 2025)
Remission announced	February 2026

How is Magda Szubanski doing now?

Current health status

Magda Szubanski is in remission. In February 2026, she shared a video on Instagram confirming she had finished chemotherapy and that her cancer was in remission, as reported by ABC News (Australian public broadcaster). She was careful to note that remission is not a complete cure — a solid remission, she said, ideally means keeping the cancer at bay for quite a while.

Recent public appearances

Szubanski has not returned to a full public schedule, but her Instagram account — which has over 406,000 followers — remains her primary channel for updates. In her February 2026 video, she appeared visibly healthier than in her May 2025 announcement, speaking directly to fans about her treatment journey.

The upshot

Szubanski’s candid updates have turned a private health battle into a public resource. For Australians facing a rare cancer diagnosis, her willingness to name the treatment protocol and the hospital system provides a concrete starting point for their own research.

Bottom line: Magda Szubanski is in remission after completing chemotherapy for stage 4 mantle cell lymphoma. For fans following her journey, the key takeaway is that remission is not a cure — but it is a meaningful milestone that buys time and quality of life.

Is Magda Szubanski in remission?

Details of remission announcement

Yes. On 27 February 2026, Szubanski posted a video on Instagram confirming she had finished chemotherapy and was in remission. ABC News (Australian public broadcaster) reported that she described the remission as “solid” but not a complete cure. The announcement was also covered by BBC News (UK-based international news service), which noted she had first revealed the diagnosis in May 2025.

Timeline from diagnosis to remission

May 2025: Szubanski announces stage 4 mantle cell lymphoma diagnosis via Instagram (Instagram (Magda Szubanski))
Late 2025: Undergoes chemotherapy following the Nordic protocol (The Sydney Morning Herald)
February 2026: Announces completion of chemotherapy and remission (ABC News)

The pattern: from diagnosis to remission in roughly nine months. For a stage 4 cancer described as fast-moving, that timeline is notable — but Szubanski herself has stressed that remission is not a cure.

What to watch

Mantle cell lymphoma is largely considered incurable with current therapies, according to The Conversation (academic analysis platform). The question for Szubanski — and for anyone with this diagnosis — is how long remission holds before recurrence.

The implication: a 9-month treatment window is fast for stage 4, but the underlying disease remains uncurable with current tools.

How did Magda Szubanski get diagnosed?

Symptoms that led to diagnosis

Szubanski said the lymphoma was discovered incidentally during a breast screen when lymph nodes were found to be enlarged, according to her Instagram announcement (personal account). She also said she had been feeling unwell for some time before the diagnosis — a common pattern with mantle cell lymphoma, which often presents with vague symptoms like fatigue, night sweats, and swollen lymph nodes before a formal diagnosis is made.

Diagnosis process for mantle cell lymphoma

Diagnosis typically involves a lymph node biopsy, blood tests, and imaging scans to determine the stage. In Szubanski’s case, the cancer was already at stage 4 — the most advanced phase, indicating spread to other tissues, as The Conversation (academic analysis platform) explained. The incidental discovery during a routine breast screen highlights how this cancer can be hidden until it has progressed significantly.

The catch

Mantle cell lymphoma is often diagnosed at an advanced stage because early symptoms — fatigue, swollen lymph nodes, night sweats — are easy to dismiss. Szubanski’s case is a reminder that a routine screening can catch what the body itself may not yet be loudly signalling.

The pattern: stage 4 is the norm for this cancer because it hides behind vague symptoms.

What is mantle cell lymphoma?

Definition and characteristics

Mantle cell lymphoma is a rare and fast-moving form of blood cancer. It is classified as a non-Hodgkin lymphoma and affects B-cells, a type of white blood cell. ABC News (Australian public broadcaster) reported that it is one of about 60 subtypes of non-Hodgkin lymphoma, named after the mantle zone of lymph nodes where it originates.

Treatment options and prognosis

Treatment commonly includes R-CHOP chemotherapy and may involve a stem cell transplant, according to The Conversation (academic analysis platform). Szubanski said she was following the Nordic protocol, which The Sydney Morning Herald (Australian daily newspaper) reported aims to prevent recurrence and potentially cure the disease. The same article noted that first rounds of treatment are often successful at putting lymphoma into remission, but recurrence is frequent after a short period.

Bottom line: Mantle cell lymphoma is a rare, fast-moving blood cancer that is largely considered incurable with current therapies. For patients like Szubanski, the goal is achieving a solid remission that can be maintained for as long as possible.

What this means: treatment buys time, not a clean cure — remission is a holding action against recurrence.

Did the cast of Kath and Kim get along?

Magda Szubanski’s relationship with co-stars

Szubanski has been candid about the on-set dynamics of Kath & Kim. In a 2023 interview, she said she didn’t like Gina Riley and Jane Turner during the early days of the show, as reported by Now To Love (Australian lifestyle publication). The tension, she explained, stemmed from the pressure of creating a hit show — not from personal animosity.

On-set dynamics of Kath and Kim

The three women — Szubanski, Riley, and Turner — have since reconciled publicly. Szubanski has described their relationship as professional and respectful, with the early friction giving way to mutual admiration. The show, which ran from 2002 to 2007, remains one of Australia’s most beloved comedies.

The pattern: creative tension is common in ensemble comedy, and Szubanski’s willingness to discuss it openly has only deepened fans’ appreciation for the show’s behind-the-scenes reality.

Timeline: Magda Szubanski’s life and health journey

12 April 1961: Magda Szubanski born in Liverpool, England.
1990s: Rises to fame on Australian sketch comedy show Fast Forward.
1995: Appears in the film Babe.
2002–2007: Stars as Sharon Strzelecki in the TV series Kath & Kim.
May 2025: Announces diagnosis of stage 4 mantle cell lymphoma.
February 2026: Announces she is in remission from mantle cell lymphoma.

The pattern: a career spanning four decades, with a sudden pivot in 2025 from public performer to public patient. For Szubanski, the shift has been characteristically honest — and unusually educational for the rest of us.

Confirmed facts and what remains unclear

Confirmed facts

Magda Szubanski was diagnosed with stage 4 mantle cell lymphoma in May 2025 (Instagram (Magda Szubanski))
She announced she is in remission in February 2026 (ABC News)
She is an Australian comedian and actress known for Kath & Kim

What’s unclear

Specific details of her ongoing treatment plan are not publicly detailed
Long-term prognosis for her specific case is not publicly available
Her description of the cancer as “rare and fast-moving” is based on her own social media account
Her statement about receiving the Nordic protocol treatment comes from a single personal update

Quotes from Magda Szubanski and news reports

“It’s not a complete cure. But a solid remission ideally means I can keep it at bay for quite a while.”

— Magda Szubanski, via ABC News

“I have a rare and fast-moving blood cancer called mantle cell lymphoma. I’ve started one of the best treatments available — the Nordic protocol.”

— Magda Szubanski, via Instagram

“Magda Szubanski has announced she is in remission after treatment for a rare and aggressive form of cancer.”

— BBC News

“Mantle cell lymphoma is largely considered incurable with current therapies. Treatment commonly includes R-CHOP and may involve a stem cell transplant.”

— The Conversation

Summary: What Szubanski’s journey means

Magda Szubanski’s public health journey has done something rare: it has turned a celebrity cancer diagnosis into a teachable moment about a little-known blood cancer. Her willingness to name the treatment protocol, share the emotional reality, and clarify that remission is not a cure has given Australians a real-world case study in mantle cell lymphoma. For anyone facing a similar diagnosis, the implication is clear: ask about the Nordic protocol, seek specialist care, and understand that a solid remission — while not a cure — can buy meaningful time.

Additional sources

smh.com.au, survivornet.com, theconversation.com, bbc.com, sbs.com.au, abc.net.au, facebook.com, instagram.com, facebook.com, gcn.ie

Frequently asked questions

What type of cancer did Magda Szubanski have?

She was diagnosed with stage 4 mantle cell lymphoma, a rare and fast-moving form of non-Hodgkin lymphoma that affects B-cells.

What is the survival rate for mantle cell lymphoma?

Mantle cell lymphoma is largely considered incurable with current therapies, according to The Conversation. However, first rounds of treatment are often successful at putting the lymphoma into remission, though recurrence is frequent after a short period.

How old is Magda Szubanski?

She was born on 12 April 1961, making her 64 years old as of 2025.

What is Magda Szubanski’s height?

Magda Szubanski is approximately 1.65 m (5 ft 5 in) tall.

What is Magda Szubanski’s most famous role?

She is best known for playing Sharon Strzelecki in the Australian comedy series Kath & Kim (2002–2007).

Is Magda Szubanski on Instagram?

Yes, her Instagram handle is @magduszubanski, where she has over 406,000 followers and regularly posts updates about her health and life.

What awards has Magda Szubanski won?

She has won multiple Logie Awards and an Australian Film Institute (AFI) Award. She was also awarded an honorary doctorate from the University of New South Wales for her advocacy work.